$ ^{22} $ Seligman SJ. Reduction in antibiotic costs by restricting use of an oral cephalosporin. Am J Med 1981; 71: 941-944.

$ ^{23} $ Britton HL, Schwinghammer TL, Romano MJ. Cost containment through restriction of cephalosporins. Am J Hosp Pharm 1981; 38: 1897-1900.

$ ^{24} $ Hayman JN, Sbravati EC. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Am J Hosp Pharm 1985; 42: 1343-1347.

$ ^{25} $ Woodward RS, Medoff G, Smith MD, Gray JL. Antibiotic cost savings from formulary restrictions and physician monitoring in a medicalschool-affiliated hospital. Am J Med 1987; 83: 817-823.

$ ^{26} $ Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: Experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991; 90: 439-444.

$ ^{27} $ Maswoswe JJ, Okpara AU. Enforcing a policy for restricting antimicrobial drug use. Am J Health Syst Pharm 1995; 52: 1433-1435.

$ ^{28} $ White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25: 230-239.

$ ^{29} $ Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994; 120: 272-277.

$ ^{30} $ Morimoto Y, Sugiura T, Tatebayashi S, et al. Reduction in incidence of methicillin-resistant Staphylococcus aureus (MRSA) after radical surgery for head and neck cancer. Spec Care Dentist. 2006; 26: 209-213.

$ ^{31} $ Nagashima G, Kikuchi T, Tsuyuzaki H, et al. To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization? J Infect Chemother. 2006; 12: 363-365.

$ ^{32} $ Kikuchi T, Nagashima G, Taguchi K, et al. Contaminated oral intubation equipment associated with an outbreak of carbapenem-resistant Pseudomonas in an intensive care unit. J Hosp Infect. 2007; 65: 54-57.

$ ^{33} $ Konishi T, Watanabe T, Morikane K, et al. Prospective surveillance effectively reduced rates of surgical site infection associated with elective colorectal surgery at a university hospital in Japan. Infect Control Hosp Epidemiol. 2006; 27: 526-8. Epub 2006 Apr 20.

$ ^{34} $ Yanai M, Uehara Y, Takahashi S. Surveillance of infection control procedures in dialysis units in Japan: a preliminary study. Ther Apher Dial. 2006; 10: 78-86.

$ ^{35} $ Takahashi H, Kramer MH, Yasui Y, et al. Nosocomial Serratia marcescens outbreak in Osaka, Japan, from 1999 to 2000. Infect Control Hosp Epidemiol. 2004 Feb; 25(2): 156-61.

$ ^{36} $ Morikane K, Nishioka M, Tanimura H, et al. Using surveillance data to direct infection control efforts to reduce surgical-site infections following clean abdominal operations in Japan. Infect Control Hosp Epidemiol. 2002 Jul; 23(7): 404-406.

$ ^{37} $ Lahaye D, Strauss P, Baleux C, et al. Cost-benefit analysis of hepatitis-B vaccination. Lancet. 1987 22: 441-3.

$ ^{38} $ Asari S, Deguchi M, Tahara K, et al. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control. 2003; 31: 157-162.